Mounjaro and the Morning After Pill: Does Tirzepatide Affect Emergency Contraception?

Does Mounjaro slow the absorption of the morning after pill?

Tirzepatide is a dual GIP and GLP-1 receptor agonist, and one of its established effects is slowing gastric emptying, that is, your stomach takes longer than usual to move food and anything else you have swallowed into the small intestine, where absorption mostly happens. For most oral medicines taken regularly, this delay is a minor inconvenience at most. For a medicine where timing is the entire point, the picture changes.

The morning after pill works within a precise window. Levonorgestrel (brands such as Levonelle) must be taken within 72 hours of unprotected sex, and its effectiveness drops hour by hour. Ulipristal acetate (ellaOne) has a 120-hour window but is similarly dependent on reaching the bloodstream quickly enough to act. If gastric emptying is slowed by Mounjaro, peak blood levels of either medicine may be reached later than expected, which, in theory, affects how reliably they work.

UK clinical guidance does not yet include a specific, published head-to-head study of tirzepatide and emergency contraceptives. What exists is strong mechanistic reasoning, the documented effect on gastric emptying, and the established NHS England position on oral contraceptives and Mounjaro more broadly. NHS England's guidance on weight-management injections is explicit: for tirzepatide specifically, women using oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. No equivalent caution applies to semaglutide.

You can check the relevant section of that NHS England page yourself in under a minute, it is publicly accessible and sets out the oral contraceptive advice clearly.

Is the morning after pill a different situation from a regular contraceptive pill?

Yes, in a clinically important way. A regular combined or progestogen-only pill is taken daily, and a small delay in absorption on any single day is generally absorbed (so to speak) into the routine. The morning after pill is a one-off, high-stakes dose. You take it once, in a short window, and the absorbed drug level at the right time is what determines whether it is effective.

Levonorgestrel and ulipristal acetate are both oral tablets. If tirzepatide has slowed your gastric emptying on the day you take either one, the drug may sit in your stomach longer before reaching your small intestine. The product information for both medicines (available on the eMC) does not explicitly account for gastric-emptying delays caused by GLP-1 or dual-agonist medicines, this is an emerging area of clinical awareness rather than a long-standing labelled interaction.

What this means practically: you should not assume the morning after pill will work exactly as it would without Mounjaro on board. That is not a reason to avoid taking it (it remains your best available option in the window) but it is a reason to speak to a pharmacist or clinician on the same day rather than waiting to see whether it worked.

For context on how tirzepatide works more broadly, our tirzepatide overview covers the mechanism in fuller detail.

What should you actually do if you have taken the morning after pill while on Mounjaro?

Take it anyway. Time spent worrying is time the drug could have been working. Then act quickly.

Contact a sexual health clinic, your GP, or a pharmacist the same day. Explain that you are taking Mounjaro and have taken emergency contraception. A clinician may advise a copper intrauterine device (IUD) as a backup, this is the most effective form of emergency contraception and is not affected by gastric emptying at all, since it is not an oral medicine. It can be fitted up to five days after unprotected sex.

It is also worth reviewing your ongoing contraception. The NHS England oral-contraceptive caution for Mounjaro covers the first four weeks of treatment and the four weeks following each dose increase. If you are currently on the tirzepatide dose-escalation schedule, this period of heightened absorption uncertainty recurs with each step up. Our page on whether dose increases are always required may help you understand the titration process and when the escalation phase typically ends.

If you have not yet started Mounjaro and are thinking ahead, it is worth raising your contraception needs at the clinical consultation stage. A prescriber can factor this into their assessment and advise on non-oral options while you are in the dose-increase phase. Many people also find it helpful to read about whether to take Mounjaro in the morning or at night, including how timing choices interact with your wider routine, on our dedicated page.

For general questions about Mounjaro as a treatment, the Mounjaro overview and our weight-loss treatment page cover eligibility and process. If you want to understand the private-prescription cost landscape before committing to a consultation, the context around recent price changes is worth reading. Some patients also ask whether a Mounjaro pill might eventually change these absorption considerations, and our dedicated page covers what is currently known about oral formulations.

If you have specific questions our prescribers can help you think through, starting a free consultation puts your case in front of a GPhC-registered Independent Prescriber the same day, a real clinician, not a form-processing algorithm.